Night eating syndrome (NES) is a specific eating disorder characterized by a delayed circadian eating pattern: morning anorexia, evening hyperphagia (50% or more of daily calories after dinner), and nocturnal awakening to eat. It affects approximately 6 to 15% of adults with diabetes — substantially higher than the 1 to 2% general population prevalence. The disorder is distinct from binge eating disorder (episodes are continuous low-grade rather than binge-style) and from late-night snacking (which most people do occasionally without meeting full disorder criteria). For adults with diabetes, NES has clinically meaningful consequences: sustained overnight hyperglycemia, disrupted dawn phenomenon dynamics, and contribution to A1C elevation of 0.3 to 0.7 percentage points compared with adults consuming the same calories on a normal schedule.
NES Diagnostic Criteria
- Morning anorexia: little or no appetite for breakfast for at least 4 days per week.
- Evening hyperphagia: at least 50% of daily caloric intake consumed after the evening meal, OR awakening from sleep to eat at least 4 nights per week.
- Insomnia or fragmented sleep: occurring at least 4 nights per week.
- Awareness: episodes occur with full consciousness, distinguishing from sleep-related eating disorder (SRED).
- Distress: marked distress and/or impairment from the pattern.
- Persistence: pattern lasting at least 3 months.
- Not better explained: by binge eating disorder or another condition.
NES Prevalence in Diabetes
| Population | NES prevalence | Notes |
|---|---|---|
| General US adults | 1-2% | Baseline reference |
| Type 2 diabetes | 6-15% | ~5-10× elevated |
| Obesity (BMI ≥30) | 6-8% | Elevated |
| Bariatric surgery candidates | 9-31% | Highly variable estimates |
| Major depression | 10-25% | Common comorbidity |
| Shift workers | Variable | Circadian disruption increases risk |
| Adults on certain medications | Variable | Some antipsychotics, hypnotics |
The Diabetes Impact
- Sustained overnight hyperglycemia rather than the typical post-meal-pattern dawn phenomenon.
- Insulin sensitivity is lower at night — same carbohydrate produces larger glucose excursions.
- CGM data shows elevated glucose from late evening through early morning.
- Total daily insulin needs increase but distribution becomes problematic.
- Morning fasting glucose is elevated (often 150-250 mg/dL).
- A1C elevation of approximately 0.3 to 0.7 percentage points vs same calories on normal schedule.
- Sleep disruption from nocturnal eating worsens next-day insulin sensitivity 10-20%.
- The pattern is particularly difficult to manage with mealtime insulin dosing.
The Circadian Dysrhythmia
- NES reflects a delayed pattern of food intake relative to the sleep-wake cycle.
- Cortisol rhythm may be flattened — normally peaks in morning, drops in evening.
- Melatonin and leptin patterns are often disrupted.
- Ghrelin (hunger hormone) shows altered rhythms.
- The pattern resembles “permanent jet lag” in food timing.
- Circadian misalignment itself contributes to insulin resistance independent of food choices.
NES vs Other Eating Patterns
| Pattern | Key features | Distinguishing from NES |
|---|---|---|
| Night eating syndrome (NES) | Morning anorexia, evening hyperphagia, nocturnal awakening to eat | (Reference) |
| Binge eating disorder (BED) | Loss of control episodes; not time-of-day specific | BED episodes are discrete; NES is continuous |
| Sleep-related eating disorder (SRED) | Eating during sleep walking; minimal recall | SRED has reduced consciousness; NES has full awareness |
| Late-night snacking | Occasional evening eating | Less than 25% of calories at night; no morning anorexia |
| Bulimia (binge-purge type) | Bingeing with compensation | NES has no compensation |
| Time-restricted eating | Deliberate eating window | NES is involuntary delayed eating |
SSRI Treatment
- Sertraline is first-line and has the strongest evidence base.
- Typical doses: 50 to 200 mg daily.
- O’Reardon et al. trial: 71% response rate with sertraline.
- Mechanism likely involves serotonin’s role in circadian regulation and appetite.
- Onset of effect: 2-4 weeks.
- Other SSRIs (escitalopram, fluoxetine) likely have similar effects but less direct evidence.
- For adults with diabetes, SSRIs have minimal direct glucose effects — favorable profile.
Behavioral Approaches
- Forced morning eating: eat a substantial breakfast even without appetite; reset circadian eating rhythm.
- Structured meal timing: regular meals at consistent times; prevent decision-fatigue evening cravings.
- Evening eating window: gradually shift eating earlier; cut off after specific time (e.g., 8 pm).
- Sleep hygiene: consistent bedtime, dark room, no screens before bed.
- Light therapy: morning bright light (10,000 lux for 30 min) can phase-advance circadian rhythm.
- CBT-NES: structured 10-12 sessions addressing eating timing, sleep, mood.
- Reduce evening food cues: don’t keep accessible food in bedroom; eat at table not couch.
Light Therapy for NES
- Morning bright light (10,000 lux for 30 minutes within 1 hour of waking) can phase-advance the circadian rhythm.
- Mechanism: suppresses morning melatonin, advances circadian timing.
- Some trials show benefit; effect sizes smaller than SSRIs.
- Useful adjunct to other treatments.
- Particularly relevant for adults at northern latitudes where winter light exposure is reduced.
- Same equipment as for seasonal affective disorder.
Sleep Disorders and NES
- Insomnia is part of the NES diagnostic criteria; sleep treatment is essential.
- Sleep apnea is more common in NES; screening is reasonable.
- Treating sleep apnea (CPAP) sometimes improves NES.
- Avoid late-evening caffeine — compounds insomnia and NES drive.
- Hypnotic medications (zolpidem, eszopiclone) sometimes used but caution because they can trigger sleep-related eating disorder (SRED) in vulnerable adults.
- Melatonin (1-3 mg at bedtime) may help with sleep initiation; mixed evidence for NES specifically.
Medication Effects to Consider
- Some antipsychotics (olanzapine, quetiapine, mirtazapine) cause increased evening eating.
- Hypnotic medications can trigger sleep-related eating in vulnerable adults.
- Steroids (prednisone) can shift eating timing.
- Some adults on insulin develop reactive evening eating from afternoon hypoglycemia.
- Sulfonylurea-induced overnight hypoglycemia can drive nocturnal eating.
- Medication review can identify and address triggers.
Coexisting Conditions
- Major depression coexists in 25-50% of NES.
- Anxiety disorders coexist substantially.
- Substance use disorders show overlap.
- Sleep apnea is more common.
- Obesity is common (~60% of NES adults).
- Other eating disorders (BED) may coexist.
- Treatment plans address coexisting conditions.
Insulin Dosing Adjustments for NES
- Conventional dinner-time insulin dosing is often insufficient because most eating happens later.
- Hybrid closed-loop pumps adjust automatically to nighttime glucose elevation.
- Long-acting insulin may need slight increase to manage overnight glucose.
- Mealtime boluses during nocturnal eating require careful consideration of timing and dose.
- Endocrinology coordination is essential when NES is present.
- Treating the NES itself often reduces insulin requirements.
Practical Daily Strategies
- Force a morning breakfast even without appetite — protein and fiber base.
- Eat regular meals at consistent times.
- Establish evening eating cutoff (e.g., 8 pm).
- Use morning light therapy if at northern latitudes or shift work.
- Improve sleep hygiene — consistent bedtime, dark room, no screens.
- Limit evening caffeine and alcohol.
- Track CGM patterns alongside eating timing — increases self-awareness.
- Connect with a therapist experienced in eating disorders or sleep medicine.
- Discuss SSRI option with prescriber if behavioral approaches insufficient.
The Bottom Line
Night eating syndrome is a specific eating disorder characterized by morning anorexia, evening hyperphagia (50%+ of calories after dinner), nocturnal awakening to eat, and insomnia — persistent for at least 3 months. It affects approximately 6 to 15% of adults with diabetes versus 1 to 2% in the general population. For adults with diabetes, NES produces sustained overnight hyperglycemia, A1C elevation of 0.3 to 0.7 percentage points, and substantial sleep disruption that further worsens insulin sensitivity. The pattern reflects a circadian dysrhythmia rather than just emotional eating. SSRIs (sertraline 50-200 mg) are first-line pharmacotherapy with 70% response rates in trials and minimal direct glucose effects. Behavioral approaches include forced morning eating to reset circadian rhythm, structured meal timing, evening eating cutoffs, sleep hygiene, light therapy, and CBT-NES. Sleep disorders often coexist and need treatment. Coexisting depression, anxiety, and obesity are common. For adults with diabetes and NES, treating the eating disorder often substantially improves glucose control by addressing the underlying circadian dysrhythmia. The American Diabetes Association recommends mental health screening at diabetes visits — adding NES-specific questions for adults with elevated fasting glucose can catch the disorder. See our related binge eating disorder and late night eating guides for context.
